Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fpgs | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FPGS mRNA | CTD | PMID:36331819 | Fpgs | Rat | 1,1-dichloroethene | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of FPGS mRNA | CTD | PMID:26682919 | Fpgs | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FPGS mRNA | CTD | PMID:22206623 | Fpgs | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of FPGS mRNA | CTD | PMID:17108234 | Fpgs | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Fpgs (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of FPGS mRNA | CTD | PMID:17555576 | Fpgs | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FPGS mRNA | CTD | PMID:17942748 | Fpgs | Rat | 17beta-estradiol | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Estradiol results in increased expression of FPGS mRNA | CTD | PMID:39298647 | Fpgs | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fpgs (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FPGS mRNA | CTD | PMID:21570461 | Fpgs | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FPGS mRNA | CTD | PMID:28922406 | Fpgs | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FPGS mRNA | CTD | PMID:15328365 | Fpgs | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FPGS mRNA; [TIPARP gene mutant more ... | CTD | PMID:17942748|PMID:25975270 | Fpgs | Rat | 3,3',5-triiodo-L-thyronine | increases expression | EXP | | 6480464 | Triiodothyronine results in increased expression of FPGS mRNA | CTD | PMID:15953391 | Fpgs | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | bisphenol S results in decreased expression of FPGS mRNA | CTD | PMID:39298647 | Fpgs | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Fpgs (Mus musculus) | 6480464 | bisphenol S affects the methylation of FPGS gene | CTD | PMID:31683443 | Fpgs | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | FPGS (Homo sapiens) | 6480464 | Decitabine results in increased expression of FPGS mRNA | CTD | PMID:11509559 | Fpgs | Rat | 5-fluorouracil | increases response to substance | ISO | FPGS (Homo sapiens) | 6480464 | FPGS protein results in increased susceptibility to Fluorouracil | CTD | PMID:15542523 | Fpgs | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of FPGS mRNA | CTD | PMID:30047161 | Fpgs | Rat | 7-Hydroxymethotrexate | decreases activity | ISO | FPGS (Homo sapiens) | 6480464 | 7-hydroxymethotrexate results in decreased activity of FPGS protein | CTD | PMID:19426680 | Fpgs | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of FPGS mRNA | CTD | PMID:31881176 | Fpgs | Rat | acrolein | multiple interactions | ISO | FPGS (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Fpgs | Rat | aflatoxin B1 | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of FPGS mRNA | CTD | PMID:19770486 | Fpgs | Rat | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of FPGS mRNA | CTD | PMID:33354967 | Fpgs | Rat | alpha-pinene | multiple interactions | ISO | FPGS (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Fpgs | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of FPGS mRNA | CTD | PMID:30047161 | Fpgs | Rat | antimycin A | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of FPGS mRNA | CTD | PMID:33512557 | Fpgs | Rat | arsenous acid | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of FPGS mRNA | CTD | PMID:39716349 | Fpgs | Rat | benzo[a]pyrene | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of FPGS mRNA | CTD | PMID:22228805 | Fpgs | Rat | benzo[a]pyrene | decreases methylation | ISO | FPGS (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of FPGS promoter | CTD | PMID:27901495 | Fpgs | Rat | benzo[a]pyrene | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FPGS mRNA | CTD | PMID:22228805 | Fpgs | Rat | beta-lapachone | increases expression | ISO | FPGS (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of FPGS mRNA | CTD | PMID:38218311 | Fpgs | Rat | bisphenol A | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FPGS mRNA | CTD | PMID:21932408 | Fpgs | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of FPGS mRNA | CTD | PMID:30903817 | Fpgs | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FPGS mRNA | CTD | PMID:25181051|PMID:32145629 | Fpgs | Rat | bisphenol F | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | bisphenol F results in decreased expression of FPGS mRNA | CTD | PMID:38685157 | Fpgs | Rat | cadmium atom | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FPGS more ... | CTD | PMID:37236586 | Fpgs | Rat | cadmium dichloride | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of FPGS mRNA | CTD | PMID:38568856 | Fpgs | Rat | cadmium dichloride | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FPGS more ... | CTD | PMID:37236586 | Fpgs | Rat | calciol | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Cholecalciferol results in decreased expression of FPGS mRNA | CTD | PMID:16508948 | Fpgs | Rat | carbon nanotube | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Nanotubes, Carbon results in increased expression of FPGS mRNA | CTD | PMID:25620056 | Fpgs | Rat | chlorpyrifos | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of FPGS mRNA | CTD | PMID:37019170 | Fpgs | Rat | choline | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Fpgs | Rat | clofibrate | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Clofibrate results in decreased expression of FPGS mRNA | CTD | PMID:17585979 | Fpgs | Rat | copper atom | multiple interactions | ISO | FPGS (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of FPGS mRNA | CTD | PMID:31162603 | Fpgs | Rat | copper(0) | multiple interactions | ISO | FPGS (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of FPGS mRNA | CTD | PMID:31162603 | Fpgs | Rat | diarsenic trioxide | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of FPGS mRNA | CTD | PMID:39716349 | Fpgs | Rat | doxorubicin | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of FPGS mRNA | CTD | PMID:29803840 | Fpgs | Rat | fenthion | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Fenthion results in decreased expression of FPGS mRNA | CTD | PMID:34813904 | Fpgs | Rat | folic acid | affects expression | ISO | FPGS (Homo sapiens) | 6480464 | Folic Acid affects the expression of FPGS mRNA | CTD | PMID:17311948 | Fpgs | Rat | folic acid | increases expression | ISO | FPGS (Homo sapiens) | 6480464 | Folic Acid deficiency results in increased expression of FPGS mRNA | CTD | PMID:18623116 | Fpgs | Rat | folic acid | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FPGS mRNA; [Methionine deficiency co-treated more ... | CTD | PMID:20938992|PMID:22206623 | Fpgs | Rat | folpet | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | folpet results in decreased expression of FPGS mRNA | CTD | PMID:31558096 | Fpgs | Rat | fumonisin B1 | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | fumonisin B1 results in decreased expression of FPGS mRNA | CTD | PMID:16221962 | Fpgs | Rat | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of FPGS mRNA | CTD | PMID:24136188 | Fpgs | Rat | GSK-J4 | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of FPGS mRNA | CTD | PMID:29301935 | Fpgs | Rat | ivermectin | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of FPGS protein | CTD | PMID:32959892 | Fpgs | Rat | L-methionine | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Fpgs | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of FPGS mRNA | CTD | PMID:24136188 | Fpgs | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of FPGS mRNA | CTD | PMID:30467583 | Fpgs | Rat | methidathion | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | methidathion results in decreased expression of FPGS mRNA | CTD | PMID:34813904 | Fpgs | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of FPGS mRNA | CTD | PMID:30047161 | Fpgs | Rat | methotrexate | increases metabolic processing | ISO | FPGS (Homo sapiens) | 6480464 | FPGS protein results in increased metabolism of Methotrexate | CTD | PMID:20072153 | Fpgs | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of FPGS mRNA | CTD | PMID:24136188 | Fpgs | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of FPGS mRNA | CTD | PMID:25729387 | Fpgs | Rat | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of FPGS mRNA | CTD | PMID:25729387 | Fpgs | Rat | ozone | multiple interactions | ISO | FPGS (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Fpgs | Rat | paracetamol | affects expression | ISO | Fpgs (Mus musculus) | 6480464 | Acetaminophen affects the expression of FPGS mRNA | CTD | PMID:17562736 | Fpgs | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of FPGS mRNA | CTD | PMID:33387578 | Fpgs | Rat | paracetamol | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of FPGS mRNA | CTD | PMID:25704631 | Fpgs | Rat | parathion | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Parathion results in decreased expression of FPGS mRNA | CTD | PMID:34813904 | Fpgs | Rat | pemetrexed | increases response to substance | ISO | FPGS (Homo sapiens) | 6480464 | FPGS protein results in increased susceptibility to Pemetrexed | CTD | PMID:17575230 | Fpgs | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fpgs (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FPGS mRNA | CTD | PMID:36331819 | Fpgs | Rat | picoxystrobin | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of FPGS mRNA | CTD | PMID:33512557 | Fpgs | Rat | pirinixic acid | increases expression | ISO | Fpgs (Mus musculus) | 6480464 | pirinixic acid results in increased expression of FPGS mRNA | CTD | PMID:15302862|PMID:18301758 | Fpgs | Rat | propiconazole | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | propiconazole results in decreased expression of FPGS mRNA | CTD | PMID:21278054 | Fpgs | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of FPGS mRNA | CTD | PMID:28374803 | Fpgs | Rat | sodium arsenite | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FPGS mRNA | CTD | PMID:38568856 | Fpgs | Rat | sodium arsenite | increases expression | ISO | FPGS (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of FPGS mRNA | CTD | PMID:39719251 | Fpgs | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of FPGS mRNA | CTD | PMID:30047161 | Fpgs | Rat | tamoxifen | affects expression | ISO | Fpgs (Mus musculus) | 6480464 | Tamoxifen affects the expression of FPGS mRNA | CTD | PMID:17555576 | Fpgs | Rat | testosterone | increases expression | ISO | FPGS (Homo sapiens) | 6480464 | Testosterone results in increased expression of FPGS mRNA | CTD | PMID:33359661 | Fpgs | Rat | tetrachloromethane | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of FPGS mRNA | CTD | PMID:27339419|PMID:31919559 | Fpgs | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FPGS mRNA | CTD | PMID:23411599 | Fpgs | Rat | thiram | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Thiram results in decreased expression of FPGS mRNA | CTD | PMID:38568856 | Fpgs | Rat | titanium dioxide | decreases methylation | ISO | Fpgs (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FPGS gene | CTD | PMID:35295148 | Fpgs | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of FPGS mRNA | CTD | PMID:25729387 | Fpgs | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of FPGS mRNA | CTD | PMID:25729387 | Fpgs | Rat | triptonide | decreases expression | ISO | Fpgs (Mus musculus) | 6480464 | triptonide results in decreased expression of FPGS mRNA | CTD | PMID:33045310 | Fpgs | Rat | urethane | decreases expression | ISO | FPGS (Homo sapiens) | 6480464 | Urethane results in decreased expression of FPGS mRNA | CTD | PMID:28818685 | Fpgs | Rat | vorinostat | increases expression | ISO | FPGS (Homo sapiens) | 6480464 | vorinostat results in increased expression of FPGS mRNA | CTD | PMID:20072153 | Fpgs | Rat | warfarin | affects response to substance | ISO | FPGS (Homo sapiens) | 6480464 | FPGS gene polymorphism affects the susceptibility to Warfarin | CTD | PMID:25079360 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















